Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Genetically-Guided Radiotherapy for the Treatment of Triple Negative Breast Cancer in Patients Undergoing Breast Conservation Surgery

Trial Status: active

This phase II trial tests how well genetically-guided radiotherapy works in treating triple negative breast cancer patients undergoing an operation to remove their tumor but not the breast itself (breast conservation surgery). In this study, patients' tumor tissue is collected and tested for certain genes to calculate the risk of cancer recurrence (“high risk” or “low risk”) and determine the amount of radiotherapy patients should receive. Radiotherapy in this trial uses high energy x-rays or electron beams to kill cancer cells and shrink tumors. Giving genetically-guided radiotherapy may be feasible and effective in controlling triple-negative breast cancer following breast conservation surgery.